Life Sciences & Healthcare segment, including trusted data assets and analytics spanning drug and device development
Price
$600,000,000
Date
2026-10-06
Buyer
Altaris
Seller
Clarivate
Type
Region
US/UK/global
Market Context
It provides a disclosed valuation for a subscription and data-intensive healthcare information business, although software, services and personnel are included.
Term
One Time
Confidence:
High
Citation:
DatFlash (2026).
"Life Sciences & Healthcare segment, including trusted data assets and analytics spanning drug and device development"
https://www.datflash.com/transaction/Altaris-buys-clarivate
https://www.datflash.com/transaction/Altaris-buys-clarivate